Page 145 - Tata_Chemicals_yearly-reports-2017-18
P. 145

6WDWHPHQW RI &DVK )ORZV IRU WKH \HDU HQGHG    0DUFK


                                                                                                         ` in crore
          Particulars                                                                   Year ended    Year ended
                                                                                     31 March, 2018  31 March, 2017
          A    Cash flows from operating activities
               Profit before tax  from continuing operations                                 903.59         804.01
               Profit before tax from discontinued operation                                1,651.71        185.59
                                                                                          2,555.30        989.60
               Adjustments for :
               Depreciation and amortisation expense                                        139.13         169.88
               Impairment of assets (note 31)                                                65.40             -     Integrated Report
               Finance costs                                                                149.92         276.66
               Interest income                                                              (14.11)        (3.01)
               Dividend income                                                             (101.98)       (105.32)
               Profit on sale of discontinued operation (note 31)                          (1,279.39)           -
               Net gain on sale of current investments                                      (49.54)        (2.30)
               Provision for employee benefits expense                                        (2.74)         28.06
               Provision for doubtful debts and advances/bad debts written off/(back)         46.15         (1.18)
               Provision for contingencies                                                   10.23          17.96
               Liabilities no longer required written back                                  (19.17)        (6.19)
               Realised foreign exchange loss due to financing activities                      3.87          69.41
               Unrealised foreign exchange (gain)/loss (net)                                 (0.31)         1.36
               Loss on assets sold or discarded (net)                                         7.38          2.15
               Operating profit before working capital changes                            1,510.14       1,437.08   Statutory Reports
               Adjustments for :
               Trade receivables, other financial assets and other assets                    (74.28)        981.19
               Inventories                                                                  110.24         356.89
               Trade payables, other financial liabilities and other liabilities              37.79         (72.26)
               Cash generated from operations                                             1,583.89       2,702.90
               Taxes paid (net of refund)                                                  (747.51)       (309.49)
               Net cash generated from operating activities                                 836.38       2,393.41
          B    Cash flows from investing activities
               Acquisition of property, plant and equipment (including capital work-in-progress)   (328.74)   (264.81)
               Acquisition of intangible assets (including intangible asset under development)   (1.16)    (2.42)
               Proceeds from sale of property, plant and equipment                           12.56          1.62
               Proceeds from sale of other non-current investments                          920.07          5.19
               Proceeds from sale of current investments                                  14,708.51      10,669.18   Financial Statements
               Purchase of non-current investments                                          (36.77)        (0.50)
               Purchase of current investments                                           (14,658.98)    (10,669.18)
               Investment in subsidiary                                                      (0.05)            -
               Bank balances not considered as cash and cash equivalent                    (450.00)            -
               Proceeds from sale of discontinued operations (net) (note 31)               2,593.98            -
               Interest received                                                              4.62          3.96
               Dividend received
                - From subsidiaries                                                          36.50          24.34
                - From joint venture                                                          9.82          21.02
                - From others                                                                55.66          59.96
               Net cash from/(used in) in investing activities                            2,866.02       (151.64)



                                                                               Standalone Financial Statements  143
   140   141   142   143   144   145   146   147   148   149   150